These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 28195861)

  • 1. Perioperative Management of a Patient With an Intrathecal Drug Delivery Device Infusing Ziconotide: A Case Report.
    Patel S; Hafez O; Sexton WJ; Edwards DA
    A A Case Rep; 2017 Feb; 8(4):78-80. PubMed ID: 28195861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and Safety of Intrathecal Ziconotide: Interim Analysis of the Patient Registry of Intrathecal Ziconotide Management (PRIZM).
    Deer T; Rauck RL; Kim P; Saulino MF; Wallace M; Grigsby EJ; Huang IZ; Mori F; Vanhove GF; McDowell GC
    Pain Pract; 2018 Feb; 18(2):230-238. PubMed ID: 28449352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bolus intrathecal injection of ziconotide (Prialt®) to evaluate the option of continuous administration via an implanted intrathecal drug delivery (ITDD) system: a pilot study.
    Mohammed SI; Eldabe S; Simpson KH; Brookes M; Madzinga G; Gulve A; Baranidharan G; Radford H; Crowther T; Buchser E; Perruchoud C; Batterham AM
    Neuromodulation; 2013; 16(6):576-81; discussion 582. PubMed ID: 23205907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrathecal Pharmacology Update: Novel Dosing Strategy for Intrathecal Monotherapy Ziconotide on Efficacy and Sustainability.
    Pope JE; Deer TR
    Neuromodulation; 2015 Jul; 18(5):414-20. PubMed ID: 25708382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ziconotide: an innovative alternative for intense chronic neuropathic pain].
    Valía-Vera JC; Villanueva VL; Asensio-Samper JM; López-Alarcón MD; de Andrés JA
    Rev Neurol; 2007 Dec 1-15; 45(11):665-9. PubMed ID: 18050098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of Low Dose Ziconotide as First-Line Intrathecal Monotherapy.
    Prusik J; Argoff C; Peng S; Pilitsis JG
    Neuromodulation; 2017 Jun; 20(4):386-391. PubMed ID: 27492135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrathecal Ziconotide: Dosing and Administration Strategies in Patients With Refractory Chronic Pain.
    McDowell GC; Pope JE
    Neuromodulation; 2016 Jul; 19(5):522-32. PubMed ID: 26856969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Administering ziconotide and monitoring patients treated with ziconotide: expert opinions.
    Mitchell AA; Sapienza-Crawford AJ; Hanley KL; Lokey KJ; Wells L; McDowell GC; Stanton-Hicks M
    Pain Manag Nurs; 2013 Sep; 14(3):e84-94. PubMed ID: 23972874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recommendations for the management of chronic pain by intrathecal ziconotide].
    Tronnier V; Hofacker W; Ilias W; Kleinmann B; Koulousakis A; Kress HG; Likar R; Lux EA; Müller-Schwefe G; Schütze G; Uberall M
    MMW Fortschr Med; 2010 Oct; 152 Suppl 3():106-9. PubMed ID: 21595155
    [No Abstract]   [Full Text] [Related]  

  • 10. Ziconotide-induced psychosis: a case report.
    Phan SV; Waldfogel JM
    Gen Hosp Psychiatry; 2015; 37(1):97.e11-2. PubMed ID: 25459190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncological and functional outcome of radical cystectomy in patients with bladder cancer and obstructive uropathy.
    Gupta NP; Kolla SB; Seth A; Hemal AK; Dogra PN; Kumar R
    J Urol; 2007 Oct; 178(4 Pt 1):1206-11; discussion 1211. PubMed ID: 17698145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrathecal Drug Delivery and Spinal Cord Stimulation for the Treatment of Cancer Pain.
    Xing F; Yong RJ; Kaye AD; Urman RD
    Curr Pain Headache Rep; 2018 Feb; 22(2):11. PubMed ID: 29404792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrathecal Therapy for Chronic Pain: A Review of Morphine and Ziconotide as Firstline Options.
    Deer TR; Pope JE; Hanes MC; McDowell GC
    Pain Med; 2019 Apr; 20(4):784-798. PubMed ID: 30137539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrathecal ziconotide: a review of its use in patients with chronic pain refractory to other systemic or intrathecal analgesics.
    Sanford M
    CNS Drugs; 2013 Nov; 27(11):989-1002. PubMed ID: 23999971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro stability of low-concentration ziconotide alone or in admixtures in intrathecal pumps.
    Dupoiron D; Richard H; Chabert-Desnot V; Devys C; Leynia P; Boisdron-Celle M
    Neuromodulation; 2014 Jul; 17(5):472-82; discussion 482. PubMed ID: 24512055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Robot-assisted radical cystectomy with intracorporeal urinary diversion in patients with transitional cell carcinoma of the bladder.
    Jonsson MN; Adding LC; Hosseini A; Schumacher MC; Volz D; Nilsson A; Carlsson S; Wiklund NP
    Eur Urol; 2011 Nov; 60(5):1066-73. PubMed ID: 21852033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of laparoscopic and robot-assisted radical cystectomy with ileal conduit urinary diversion.
    Abraham JB; Young JL; Box GN; Lee HJ; Deane LA; Ornstein DK
    J Endourol; 2007 Dec; 21(12):1473-80. PubMed ID: 18186686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ziconotide: a new nonopioid intrathecal analgesic for the treatment of chronic pain.
    Wallace MS
    Expert Rev Neurother; 2006 Oct; 6(10):1423-8. PubMed ID: 17078783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M
    Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ziconotide: a clinical update and pharmacologic review.
    Pope JE; Deer TR
    Expert Opin Pharmacother; 2013 May; 14(7):957-66. PubMed ID: 23537340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.